We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Reconstructive Spinal Surgery

By HospiMedica staff writers
Posted on 30 Mar 2004
A new type of reconstructive spinal surgery involves a unique bone graft containment and reinforcement system that is implanted within the spinal vertebrae. More...
The procedure has been cleared by the U.S. Food and Drug Administration (FDA).

A miniature expandable instrument is used to shape a cavity inside the vertebral body. A conformable porous mesh sack, called OptiMesh, is then implanted into the damaged vertebra and filled with allograft, or donated bone material, to restore vertebral integrity. OptiMesh contains and reinforces the graft material, and the allograft tightly packed within OptiMesh becomes a solid implant augmenting the vertebra.

The first U.S. operation recently took place at the Northeast Georgia Medical Center (Gainesville, USA), performed by Karl D. Schultz, Jr., M.D., a neurosurgeon. The patient experienced an immediate and significant decrease in pain as a result of the surgery, and was discharged from the hospital within 24 hours.

The typical patient for the new procedure is female, over 60, with osteoporosis and sudden unremitting back pain due to minor trauma, according to Dr. Steve Kuslich, who invented the procedure and is now a spokesperson for Spineology, Inc. (Stillwater, MN, USA). Upon examination, a doctor may diagnose an osteoporotic compression fracture with accompanying loss of vertebral body height. If left untreated, the patient will often experience more fractures and develop a "dowager's hump.”

Spineology is a medical device company now commercializing the procedure. The company notes that an estimated 70,000 fragile bone vertebral fractures occur in the United States alone each year.




Related Links:
Spineology

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.